236 related articles for article (PubMed ID: 19574461)
1. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.
Lin Z; Murtaza I; Wang K; Jiao J; Gao J; Li PF
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12103-8. PubMed ID: 19574461
[TBL] [Abstract][Full Text] [Related]
2. The Role of microRNA-23a-3p in the Progression of Human Aging Process by Targeting FOXO3a.
Wang S; Sun Y; Yao L; Xing Y; Yang H; Ma Q
Mol Biotechnol; 2024 Feb; 66(2):277-287. PubMed ID: 37087718
[TBL] [Abstract][Full Text] [Related]
3. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy.
Drawnel FM; Wachten D; Molkentin JD; Maillet M; Aronsen JM; Swift F; Sjaastad I; Liu N; Catalucci D; Mikoshiba K; Hisatsune C; Okkenhaug H; Andrews SR; Bootman MD; Roderick HL
J Cell Biol; 2012 Nov; 199(5):783-98. PubMed ID: 23166348
[TBL] [Abstract][Full Text] [Related]
4. MEF2C Directly Interacts with Pre-miRNAs and Distinct RNPs to Post-Transcriptionally Regulate miR-23a-miR-27a-miR-24-2 microRNA Cluster Member Expression.
Lozano-Velasco E; Garcia-Padilla C; Carmona-Garcia M; Gonzalez-Diaz A; Arequipa-Rendon A; Aranega AE; Franco D
Noncoding RNA; 2024 May; 10(3):. PubMed ID: 38804364
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways mediating the response to hypertrophic stress in the heart.
Force T; Hajjar R; Del Monte F; Rosenzweig A; Choukroun G
Gene Expr; 1999; 7(4-6):337-48. PubMed ID: 10440234
[TBL] [Abstract][Full Text] [Related]
6. Two birds, one stone: NFATc3 controls dual actions of miR-204 in foam cell formation.
van Solingen C; Moore KJ
Eur Heart J; 2021 Dec; 42(47):4862-4864. PubMed ID: 34571536
[No Abstract] [Full Text] [Related]
7. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
Wang K; Long B; Zhou J; Li PF
J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
[TBL] [Abstract][Full Text] [Related]
8. Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.
Wang K; Lin ZQ; Long B; Li JH; Zhou J; Li PF
J Biol Chem; 2012 Jan; 287(1):589-599. PubMed ID: 22084234
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development.
Kalsotra A; Wang K; Li PF; Cooper TA
Genes Dev; 2010 Apr; 24(7):653-8. PubMed ID: 20299448
[TBL] [Abstract][Full Text] [Related]
10. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1.
Wang JX; Jiao JQ; Li Q; Long B; Wang K; Liu JP; Li YR; Li PF
Nat Med; 2011 Jan; 17(1):71-8. PubMed ID: 21186368
[TBL] [Abstract][Full Text] [Related]
11. Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes.
Saygili E; Rana OR; Günzel C; Rackauskas G; Saygili E; Noor-Ebad F; Gemein C; Zink MD; Schwinger RH; Mischke K; Weis J; Marx N; Schauerte P
Cell Signal; 2012 Jan; 24(1):99-105. PubMed ID: 21889978
[TBL] [Abstract][Full Text] [Related]
12. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy.
Wada S; Kato Y; Okutsu M; Miyaki S; Suzuki K; Yan Z; Schiaffino S; Asahara H; Ushida T; Akimoto T
J Biol Chem; 2011 Nov; 286(44):38456-38465. PubMed ID: 21926429
[TBL] [Abstract][Full Text] [Related]
13. Newfound features associated with Hennekam Syndrome (
Safari Vejin T; Zepeda ME; Yglesias BS; Devito P
Clin Case Rep; 2023 Nov; 11(11):e7891. PubMed ID: 38028107
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA
Yuan M; Jia H; Zhao B; Zhang C; Zuo X
Open Med (Wars); 2023; 18(1):20230681. PubMed ID: 37197359
[TBL] [Abstract][Full Text] [Related]
15. ABRO1 arrests cardiomyocyte proliferation and myocardial repair by suppressing PSPH.
Wang T; Zhou LY; Li XM; Liu F; Liang L; Chen XZ; Ju J; Ponnusamy M; Wang K; Liu CY; Yan KW; Wang K
Mol Ther; 2023 Mar; 31(3):847-865. PubMed ID: 36639869
[TBL] [Abstract][Full Text] [Related]
16. Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases.
Saenz-Pipaon G; Dichek DA
Atherosclerosis; 2023 Jun; 374():44-54. PubMed ID: 36577600
[TBL] [Abstract][Full Text] [Related]
17. Preeclampsia and Fetal Growth Restriction as Risk Factors of Future Maternal Cardiovascular Disease-A Review.
Sławek-Szmyt S; Kawka-Paciorkowska K; Ciepłucha A; Lesiak M; Ropacka-Lesiak M
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294369
[TBL] [Abstract][Full Text] [Related]
18. Small non-coding RNA therapeutics for cardiovascular disease.
Shah AM; Giacca M
Eur Heart J; 2022 Nov; 43(43):4548-4561. PubMed ID: 36106499
[TBL] [Abstract][Full Text] [Related]
19. SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.
Li ZY; Lu GQ; Lu J; Wang PX; Zhang XL; Zou Y; Liu PQ
Acta Pharmacol Sin; 2023 Mar; 44(3):546-560. PubMed ID: 36042291
[TBL] [Abstract][Full Text] [Related]
20. Specific microRNAs and heart failure: time for the next step toward application?
Sigutova R; Evin L; Stejskal D; Ploticova V; Svagera Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):359-368. PubMed ID: 35726831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
